Get the Stockscreener App
42.47
0.97%
0.3712
Quidelortho Corporation stock is traded at $42.47, with a volume of 380.85K.
It is up +0.97% in the last 24 hours and down -9.38% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
See More
Previous Close:
$42.10
Open:
$42.11
24h Volume:
380.85K
Relative Volume:
0.41
Market Cap:
$2.83B
Revenue:
$2.82B
Net Income/Loss:
$-1.87B
P/E Ratio:
-1.5223
EPS:
-27.9
Net Cash Flow:
$-96.80M
1W Performance:
-2.19%
1M Performance:
-9.38%
6M Performance:
+7.38%
1Y Performance:
-37.15%
1-Day Range:
$41.51
$42.96
1-Week Range:
$41.51
$44.68
52-Week Range:
$29.73
$69.83
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
42.43 | 2.83B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
129.00 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.62 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.89 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.97 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.06 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
QuidelOrtho (QDEL) Expected to Announce Earnings on Tuesday - MarketBeat
Private Management Group Inc. Lowers Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by EMC Capital Management - MarketBeat
Gagnon Securities LLC Grows Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.8%Should You Sell? - MarketBeat
Why QuidelOrtho Stock Blasted 10% Higher Today - MSN
QuidelOrtho Corporation – Consensus ‘none’ rating and 17.5% Upside Potential - DirectorsTalk Interviews
Shareholders in QuidelOrtho (NASDAQ:QDEL) are in the red if they invested three years ago - Yahoo Finance
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - Yahoo Finance
QuidelOrtho Adds Two Independent Directors to its Board - MPO-mag
QuidelOrtho Co. (NASDAQ:QDEL) Holdings Raised by SG Americas Securities LLC - MarketBeat
Merit Financial Group LLC Makes New $301,000 Investment in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
NASDAQ: QDEL Lawsuit Update: Investors Who Lost Money With Shares of B QuidelOrtho Corporation (NASDAQ: QDEL) Should Contact the Shareholders Foundation - ACCESS Newswire
QuidelOrtho Co. (NASDAQ:QDEL) Receives $53.43 Consensus Target Price from Analysts - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Clear Harbor Asset Management LLC Makes New Investment in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues - MSN
QuidelOrtho (NASDAQ:QDEL shareholders incur further losses as stock declines 6.4% this week, taking three-year losses to 59% - Simply Wall St
QuidelOrtho may be takeover, activist target with CEO exit, share slumpanalyst - MSN
Oak Thistle LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho lets go off CEO Douglas Bryant - MSN
QuidelOrtho Breaks Below 200-Day Moving AverageNotable for QDEL - Nasdaq
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.2%Here's Why - MarketBeat
Why QuidelOrtho Shares Are Struggling Despite Optimism - TipRanks
Moody National Bank Trust Division Grows Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Corp (QDEL) Trading Down 4.21% on Jan 13 - GuruFocus.com
QuidelOrtho sees Q4 revenue $702M -$707M, consensus $698.04M - TipRanks
QuidelOrtho announces preliminary Q4 2024 revenue in range of $702 million to $707 million - MSN
QuidelOrtho reports Q4 revenue in line with guidance - Investing.com
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 - The Bakersfield Californian
Barclays PLC Sells 41,945 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho reports Q4 revenue in line with guidance By Investing.com - Investing.com South Africa
GAMMA Investing LLC Sells 640 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Quidel completes Ortho deal, emerges as QuidelOrtho - LabPulse
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PR Newswire
JPMorgan Chase & Co. Has $56.25 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
JPMorgan Chase & Co. Sells 54,506 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Immunoassay Market Strategies, Trends. Forecasts Report 2025: The Drive Towards Newer, More Efficient Diagnostic Instruments - GlobeNewswire Inc.
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
QuidelOrtho Co. (NASDAQ:QDEL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Stock Position Increased by Principal Financial Group Inc. - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Holdings Raised by Principal Financial Group Inc. - Defense World
QuidelOrtho files to sell 8.26M shares of common stocks by selling shareholders - MSN
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Barclays PLC - MarketBeat
Geode Capital Management LLC Buys 16,059 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects? - MSN
Insider Buying: QuidelOrtho President Bought US$250k Of Shares - Yahoo Finance
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corporation Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
1.21%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):